FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2291783477> ?p ?o ?g. }

• W2291783477 endingPage "911" @default.
• W2291783477 startingPage "911" @default.
• W2291783477 abstract "Naringenin (NRG), a flavonoid compound, had been reported to exhibit extensive pharmacological effects, but its water solubility and oral bioavailability are only~46±6 µg/mL and 5.8%, respectively. The purpose of this study is to design and develop NRG-loaded solid lipid nanoparticles (NRG-SLNs) to provide prolonged and sustained drug release, with improved stability, involving nontoxic nanocarriers, and increase the bioavailability by means of pulmonary administration. Initially, a group contribution method was used to screen the best solid lipid matrix for the preparation of SLNs. NRG-SLNs were prepared by an emulsification and low-temperature solidification method and optimized using an orthogonal experiment approach. The morphology was examined by transmission electron microscopy, and the particle size and zeta potential were determined by photon correlation spectroscopy. The total drug content of NRG-SLNs was measured by high-performance liquid chromatography, and the encapsulation efficiency (EE) was determined by Sephadex gel-50 chromatography and high-performance liquid chromatography. The in vitro NRG release studies were carried out using a dialysis bag. The best cryoprotectant to prepare NRG-SLN lyophilized powder for future structural characterization was selected using differential scanning calorimetry, powder X-ray diffraction, and Fourier transform infrared spectroscopy. The short-term stability, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay, cellular uptake, and pharmacokinetics in rats were studied after pulmonary administration of NRG-SLN lyophilized powder. Glycerol monostearate was selected to prepare SLNs, and the optimal formulation of NRG-SLNs was spherical in shape, with a particle size of 98 nm, a polydispersity index of 0.258, a zeta potential of -31.4 mV, a total drug content of 9.76 mg, an EE of 79.11%, and a cumulative drug release of 80% in 48 hours with a sustained profile. In addition, 5% mannitol (w/v) was screened as a cryoprotectant. Fourier transform infrared spectroscopy, differential scanning calorimetry, and powder X-ray diffraction studies confirmed that the drug was encapsulated into SLNs in an amorphous form. The lyophilized powder was stable at both refrigeration (4°C) and ambient temperature (25°C) for 3 months, and the MTT assay demonstrated that the SLNs were nontoxic. The cellular uptake of fluorescein isothiocyanate-labeled SLNs in A549 cells was highly time dependent over a period of 3 hours, while the pharmacokinetic study in Sprague Dawley rats showed that the relative bioavailability of NRG-SLNs was 2.53-fold greater than that of NRG suspension after pulmonary administration. This study shows that SLNs offer a promising pulmonary delivery system to increase the bioavailability of the poorly water-soluble drug NRG." @default.
• W2291783477 created "2016-06-24" @default.
• W2291783477 creator A5019409268 @default.
• W2291783477 creator A5027944033 @default.
• W2291783477 creator A5037315283 @default.
• W2291783477 creator A5037997848 @default.
• W2291783477 creator A5039099827 @default.
• W2291783477 creator A5042912398 @default.
• W2291783477 creator A5051766678 @default.
• W2291783477 creator A5060002817 @default.
• W2291783477 creator A5080665451 @default.
• W2291783477 creator A5080804832 @default.
• W2291783477 date "2016-03-01" @default.
• W2291783477 modified "2023-10-02" @default.
• W2291783477 title "Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics" @default.
• W2291783477 cites W1579046626 @default.
• W2291783477 cites W1806341717 @default.
• W2291783477 cites W1964392067 @default.
• W2291783477 cites W1971120211 @default.
• W2291783477 cites W1972516841 @default.
• W2291783477 cites W1975480344 @default.
• W2291783477 cites W1982675616 @default.
• W2291783477 cites W1991592195 @default.
• W2291783477 cites W1997003987 @default.
• W2291783477 cites W1997061160 @default.
• W2291783477 cites W1999166183 @default.
• W2291783477 cites W2018218781 @default.
• W2291783477 cites W2024826190 @default.
• W2291783477 cites W2029999940 @default.
• W2291783477 cites W2037602102 @default.
• W2291783477 cites W2041534729 @default.
• W2291783477 cites W2044070617 @default.
• W2291783477 cites W2049511402 @default.
• W2291783477 cites W2050063412 @default.
• W2291783477 cites W2050190157 @default.
• W2291783477 cites W2051102050 @default.
• W2291783477 cites W2054660789 @default.
• W2291783477 cites W2055641850 @default.
• W2291783477 cites W2065627183 @default.
• W2291783477 cites W2066027810 @default.
• W2291783477 cites W2072329683 @default.
• W2291783477 cites W2074037878 @default.
• W2291783477 cites W2075802147 @default.
• W2291783477 cites W2076609240 @default.
• W2291783477 cites W2079258400 @default.
• W2291783477 cites W2089404718 @default.
• W2291783477 cites W2089481112 @default.
• W2291783477 cites W2089811595 @default.
• W2291783477 cites W2093641552 @default.
• W2291783477 cites W2094858738 @default.
• W2291783477 cites W2094970696 @default.
• W2291783477 cites W2099784932 @default.
• W2291783477 cites W2111467671 @default.
• W2291783477 cites W2120166044 @default.
• W2291783477 cites W2126120311 @default.
• W2291783477 cites W2168656522 @default.
• W2291783477 cites W2316174168 @default.
• W2291783477 cites W2333886836 @default.
• W2291783477 cites W2431839356 @default.
• W2291783477 cites W264475111 @default.
• W2291783477 doi "https://doi.org/10.2147/dddt.s97738" @default.
• W2291783477 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4780207" @default.
• W2291783477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27041995" @default.
• W2291783477 hasPublicationYear "2016" @default.
• W2291783477 type Work @default.
• W2291783477 sameAs 2291783477 @default.
• W2291783477 citedByCount "50" @default.
• W2291783477 countsByYear W22917834772017 @default.
• W2291783477 countsByYear W22917834772018 @default.
• W2291783477 countsByYear W22917834772019 @default.
• W2291783477 countsByYear W22917834772020 @default.
• W2291783477 countsByYear W22917834772021 @default.
• W2291783477 countsByYear W22917834772022 @default.
• W2291783477 countsByYear W22917834772023 @default.
• W2291783477 crossrefType "journal-article" @default.
• W2291783477 hasAuthorship W2291783477A5019409268 @default.
• W2291783477 hasAuthorship W2291783477A5027944033 @default.
• W2291783477 hasAuthorship W2291783477A5037315283 @default.
• W2291783477 hasAuthorship W2291783477A5037997848 @default.
• W2291783477 hasAuthorship W2291783477A5039099827 @default.
• W2291783477 hasAuthorship W2291783477A5042912398 @default.
• W2291783477 hasAuthorship W2291783477A5051766678 @default.
• W2291783477 hasAuthorship W2291783477A5060002817 @default.
• W2291783477 hasAuthorship W2291783477A5080665451 @default.
• W2291783477 hasAuthorship W2291783477A5080804832 @default.
• W2291783477 hasBestOaLocation W22917834771 @default.
• W2291783477 hasConcept C112705442 @default.
• W2291783477 hasConcept C121332964 @default.
• W2291783477 hasConcept C147789679 @default.
• W2291783477 hasConcept C155672457 @default.
• W2291783477 hasConcept C171250308 @default.
• W2291783477 hasConcept C178790620 @default.
• W2291783477 hasConcept C181389837 @default.
• W2291783477 hasConcept C18150654 @default.
• W2291783477 hasConcept C185592680 @default.
• W2291783477 hasConcept C187530423 @default.
• W2291783477 hasConcept C192562407 @default.
• W2291783477 hasConcept C199529486 @default.

• next